Clinical Trials Logo

Clinical Trial Summary

Mesial temporal lobe epilepsy (mTLE) is the most classical subtype of temporal lobe epilepsy, which is the indication of surgical intervention after evaluation. Until now, anterior temporal lobectomy (ATL) is still the recommended treatment for mTLE. However, evidences are accumulated including post ATL tetartanopia and memory deterioration and new minimized invasive treatments are introduced. Stereotactic EEG (SEEG) guided radio-frequency thermocoagulation (RF-TC) is one of the option with lower seizure freedom but with higher neurological function reservation. This study is aiming at comparison of the efficacy and safety between SEEG guided RF-TC and classical ATL in the treatment of mTLE.


Clinical Trial Description

Nowadays, more and more patients received SEEG implantation for the evaluation of intractable seizures. SEEG is not only a diagnostic method to locate the origin of the epileptic seizures but also a media to treat or to cure this disease. Using radiofrequency thermocoagulation, we are able to coagulate some part of the brain guided by SEEG. However, until now, we don't have high level evidence for the efficacy and safety of RF-TC. In our resent series, we found the 1 year seizure free rate of mTLE patients after RF-TC is about 80% without any notable complication. In this trail, we will compare the efficacy as well as the safety of anterior temporal lobectomy with RF-TC for the mTLE patients, including the 1 year Engel class, perioperative complications, cognitive function, visual field, etc. Thus we can provide more high level evidence on the usage of SEEG guided RF-TC on mTLE patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03941613
Study type Interventional
Source Xuanwu Hospital, Beijing
Contact
Status Completed
Phase N/A
Start date August 5, 2019
Completion date January 5, 2023

See also
  Status Clinical Trial Phase
Completed NCT00001672 - Language Localization Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Patients With Epilepsy N/A
Active, not recruiting NCT04897776 - Stimulation of the Thalamus for Arousal Restoral in Temporal Lobe Epilepsy N/A
Recruiting NCT05947656 - Evaluation of the NaviFUS System in Drug Resistant Epilepsy N/A
Not yet recruiting NCT06036732 - A New Approach in Intensive Care Unit Consciousness Assessment: FIVE Score
Recruiting NCT04164056 - Hippocampal and Thalamic DBS for Bilateral Temporal Lobe Epilepsy Phase 4
Completed NCT03265925 - Brain Network Activation Analysis in Epilepsy
Enrolling by invitation NCT02151175 - Low-intensity Focused Ultrasound Pulsation (LIFUP) for Treatment of Temporal Lobe Epilepsy N/A
Recruiting NCT03478852 - Investigating Epilepsy: Screening and Evaluation
Recruiting NCT01273129 - Surgery as a Treatment for Medically Intractable Epilepsy
Not yet recruiting NCT06057233 - Innovative MRI to Localize the Epileptic Zone
Withdrawn NCT02913742 - The Utility of NIOM During LITT for Refractory MTLE N/A
Recruiting NCT04649008 - Localizing Epileptic Networks Using MRI and iEEG Early Phase 1
Completed NCT00931619 - GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major Depression
Recruiting NCT04717388 - Pathophysiology, Psycho-emotional and Cognitive Functioning Associated With Tinnitus N/A
Completed NCT00706160 - Language Mapping in Patients With Epilepsy
Recruiting NCT05339438 - Pre-operative Mapping of the Anterior Temporal Lobe Using Functional MRI Innovative Techniques in in Drug-resistant Epileptic Patients N/A
Not yet recruiting NCT04871555 - Structural Cartography of the Insula in Temporal Epilepsy Patients
Completed NCT04169581 - A Deep Learning Framework for Pediatric TLE Detection Using 18F-FDG-PET Imaging
Completed NCT00040326 - Early Surgical Intervention to Treat Epilepsy Phase 3
Not yet recruiting NCT06422923 - Effect of NRTX-1001, a Cellular Therapy Product, for the Treatment of Refractory Bilateral TLE Phase 1